Related content

Primary central nervous system (CNS) lymphoma in immunocompetent patients

By Plasswilm L.   Herrlinger U.   Korfel A.   Weller M.   Küker W.   Kanz L.   Thiel E.   Bamberg M.  

Annals of Hematology, Vol. 81, Iss. 8, 2002-08 ,pp. : 415-423

Springer Publishing Company

Access to resources Recommend Favorite

Secondary central nervous system involvement in 599 patients with diffuse large B-cell lymphoma: are there any changes in the rituximab era?

By Deng Lijuan   Song Yuqin   Zhu Jun   Zheng Wen   Wang Xiaopei   Xie Yan   Lin Ningjing   Tu Meifeng   Ping Lingyan   Ying Zhitao   Liu Weiping   Zhang Chen  

International Journal of Hematology, Vol. 98, Iss. 6, 2013-12 ,pp. : 664-671

Springer Publishing Company

Access to resources Recommend Favorite

Readministration of High-Dose Methotrexate in a Patient with Suspected Immediate Hypersensitivity and T-cell Acute Lymphoblastic Lymphoma

By Kohli Anita   Ferencz Thomas M.   Calderon Jose G.  

Allergy and Asthma Proceedings, Vol. 25, Iss. 4, 2004-07 ,pp. : 249-252

OceanSide Publications, Inc

Access to resources Recommend Favorite

Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement

By Lee Keun-Wook  

Annals of Hematology, Vol. 88, Iss. 9, 2009-09 ,pp. : 829-838

Springer Publishing Company

Access to resources Recommend Favorite

International Central Nervous System and Ocular Lymphoma Workshop: Recommendations for the Future

By Nussenblatt Robert   Chan Chi-Chao   Wilson Wyndham   Hochman Jacob   Gottesman Michael    

Ocular Immunology and Inflammation, Vol. 14, Iss. 3, 2006-05 ,pp. : 139-144

Informa Healthcare

Access to resources Recommend Favorite